Author:
Prabhash Kumar,Behel Vichitra,Noronha Vanita,Patil Vijay,Menon Nandini,Chandrani Pratik,Kumar Rajiv,Rastogi Shivam,Mahajan Abhishek,Chougule Anuradha,Dutt Amit
Subject
Cancer Research,Oncology (nursing),Drug Guides,Ophthalmology
Reference20 articles.
1. Co-alteration of EGFR mutation and ALK rearrangement in non-small cell lung cancer: Case series;Shin;Medicine,2019
2. Epidermal growth factor receptor-mutated non-small-cell lung cancer: A primer on contemporary management;Rajendra;Cancer Res Stat Treat,2019
3. EGFR mutations in Indian lung cancer patients: Clinical correlation and outcome to EGFR targeted therapy;Noronha;PLoS One,2013
4. Screening for EGFR mutations in lung cancer, A report from India;Sahoo;Lung Cancer,2011
5. EGFR testing in lung cancer is ready for prime time;Hirsch;Lancet Oncol,2009
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The mighty minions of non-small-cell lung cancer: EGFR, ALK, and ROS1;Cancer Research, Statistics, and Treatment;2024-01
2. Challenges and breakthroughs: ALK alteration detection in non-small-cell lung carcinoma;Cancer Research, Statistics, and Treatment;2023
3. ALK-driven NSCLC: A narrative review - Part I;Cancer Research, Statistics, and Treatment;2023
4. Lung cancer with dual EGFR and ALK driver alterations at baseline: a retrospective observational cohort study;Acta Oncologica;2022-08-16
5. Authors’ reply to Sahoo, and Bharath and Malik;Cancer Research, Statistics, and Treatment;2022-07